Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS4800 Phase 1 study in healthy subjects
NCT04991909Phase 1Unknown
- Sponsor
- Hengrui
- Start
- Aug 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in pain comparing Treatment group A (HRS4800) with Treatment group B (Placebo) (2 arms). Primary endpoints: Number of the Adverse Events related to treatment at Day 36 and Severity of the Adverse Events related to treatment at Day 36. Status: unknown.
02
Drugs
HRS-4800
03
Conditions
pain
Beyond the preview
Go deeper on NCT04991909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04991909.